FE 201836: Clinical Trials

1 trial of FE 201836, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1

Follow FE 201836: new trials by email Literature Review of FE 201836 trials Research Report on FE 201836

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Trial to Investigate Efficacy, Safety and Tolerability of FE 201836 for Nocturia Due to Nocturnal Polyuria in Adults
FE 201836, Desmopressin, Placebo oral solution - Nocturia
Phase 2CompletedFerring Pharmaceuticals3022017-07-272022-03-02

Conditions studied

Nocturia (1)

Sponsors

Ferring Pharmaceuticals (1)

Countries

Belgium (1)  ·  Canada (1)  ·  Czechia (1)  ·  Germany (1)  ·  Hungary (1)  ·  Poland (1)  ·  United States (1)

NIH funding

2016 (1)